2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z

U.S. Outcomes in Early Liver Transplantation for Alcoholic Hepatitis: Results from the American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH).

B. Lee,¹ N. Mehta,¹ L. Platt,² G. Im,³ G. Therapondos,⁴ H. Han,⁵ D. Victor,⁶ D. Dronamraju,⁷ I. Hanouneh,⁸ M. Voigt,⁹ M. Rinella,¹⁰ S. Eswaran,¹¹ J. Hause,¹¹ C. Hsu,¹² J. Dodge,¹ Z. Li,² N. Terrault.¹
Understanding the Role of Induction Agents in Older versus Younger Kidney Transplant Recipients.

Q. Huang, F. Ammary, M. McAdams-DeMarco, D. Segev.
Unexplained Cost Variation for Liver Transplantation: A National Study of US Transplant Centers.

C. Santos, B. Hota, M. Hertl.
Unintended Consequence of the New Kidney Allocation System – Disproportionate Allocation of High Quality Kidneys to Highly Sensitized Recipients.

B. Murthy, N. Galvan, J. Moffett, C. O'Mahony, J. Goss, A. Rana.
Update of a Placebo-Controlled Trial of C1 Esterase Inhibitor for Prevention of Antibody Mediated Rejection (ABMR) in Highly-HLA Sensitized Patients.

A. Vo, J. Choi, A. Peng, K. Lim, L. Varanasi, R. Najjar, E. Huang, D. Puliyanda, S. Jordan.
Uptake of Extracellular Mitochondria Activates Human Endothelial Cells That Stimulate Alloreactive Effector T Cell Responses.

T. Brennan,¹ F. Feng,¹ L. Lin,¹ M. Song,¹ Q.-J. Li,² A. Kirk,^1,2 H. Xu.¹
Urinary Concentration Ability in Kidney Transplant Patients as Predictor for CKD.

P. Garcia-Garcia,¹ A. Jarque,¹ A. Rivero,¹ A. Rodriguez,¹ J. Gonzalez Posadas,¹ M. Macia,¹ V. Garcia Nieto,² J. Navarro.¹
Urinary Proteomic Biomarkers Discovery for Prediction of Acute Rejection in Kidney Transplant Recipients.

H.-Y. Jung, R. Kim, S. Park, J. Park, K. Lee, E. Lee, J.-H. Lim, K. Kim, J.-Y. Choi, J.-H. Cho, S.-H. Park, Y.-L. Kim, C.-D. Kim.
Urinary Proteomics to Diagnose Chronic-Antibody-Mediated Rejection in Pediatric Kidney Transplantation.

N. Kanzelmeyer, P. Zürbig, H. Mischack, K. Heindl Ruszai, T. Seemann, M. Hansen, M. Henn, A. Fichtner, B. Toenshoff, A. Melk, L. Pape.
Urinary Renal Progenitors Isolation: A Novel Predictor of Kidney Graft Outcome.

A. Manonelles,¹ O. Bestard,¹ M. Goma,¹ P. Romagnani,² J. M. Cruzado.¹
Urinary Retention Associated with Polyomavirus (BK) Viruria and Higher Peak Blood BK Following Kidney Transplant (KTx).

W. Cheungpasitporn,¹ H. Amer,² F. Cosio,² C. Schinstock.²
Urinary Type III Procollagen (PIIINP) Is Associated with Chronic Allograft Dysfunction and Predicts Graft Survival.

R. Yilmaz,¹ T. Yildirim,¹ D. Baydar,² B. Altun,¹ Y. Erdem.¹
Urine Biomarkers (UBio) Correlate Poorly with Pre-Liver Transplant (LT) Kidney Biopsy Findings and Post-LT Kidney Function.

H. Wadei,¹ J. Belcher,² C. Parikh,² T. Gonwa,¹ M. Mai,¹ J. Lieske.³
Uromodulin and Toll-Like Receptor 4 Levels Predict Susceptibility to Bacterial Urinary Tract Infection After Renal Transplantation.

K. Stahl,¹ H. Lührs,¹ J. Schmitz,² I. Scheffner,¹ W. Gwinner,¹ J. Bräsen,² H. Haller,¹ M. Schiffer.¹
Use of Biodegradable Stents for the Treatment of Anastomotic Biliary Strictures in Pediatric Liver Transplant Patients.

J. Quintero,¹ J. Juamperez,¹ V. Cabello,¹ M. Perez,³ I. Bilbao,² J. Molino,¹ R. Charco.²
Use of Forensic DNA Testing to Trace Unethical Organ Procurement and Organ Trafficking Practices.

M. He,^1,2 A. Corson,² Z. Wang,³ J. Russo,² T. Trey.²
Use of Hepatitis C Infected Organs for Kidney Transplantation: A Cost-Effective Analysis.

B. Kiberd,¹ K. Doucette,² K. Tennankore.¹
Use of Hepatitis C Infected Organs for Kidney Transplantation: A Medical Decision Analysis.

B. Kiberd,¹ K. Doucette,² K. Tennankore.¹
Use of Ledipasvir/Sofosbuvir with or without Ribavirin in Patients Post-Liver Transplant: Evaluation of Real-World Datasets.

S. Flamm,¹ M. Charlton,² M. Manns,³ M. Prieto,⁴ I. Fernandez,⁵ M. Londono,⁶ R. Kwok,⁷ C. Smith,⁸ S. Lee,⁹ H. Ngo,⁹ A. Osinusi,⁹ A. Copans,⁹ L. Rossaro,⁹ M. Shoreibah,¹⁰ O. Massoud,¹⁰ M. Curry,¹¹ M. Bourliere.¹²
Use of Modified Geriatric Assessment in Evaluation of Older Adults for Kidney Transplant Suitability.

K. Campbell,¹ F. Enger, E. Patrick,² M. Saunders,³ M. Josephson,¹ Y. Becker.²
Use of Pulsatile Perfusion Modifies the Effect of Delayed Graft Function on Graft Failure.

A. Thomas, A. Shaffer, A. Massie, D. Segev.
Usefulness of Multi-Detector Computed Tomography (MDCT) Scanning as a Replacement for Diethylenetriamine Pentaacetic Acid (DTPA).

H. Lee,¹ W. Han,¹ K. Huh,² M. Kim,² S. Kim,² Y. Kim,² Y. Yoon.¹
Usefulness of Valacyclovir Prophylaxis for Preventing Cytomegalovirus Infection After Anti-Thymocyte Globulin Treatment as Antirejection Therapy.

E. Ko,^1,2 J. Yu,^1,2 B. Choi,^1,2 C. Park,^1,2 Y. Kim,^1,2 C. Yang,^1,2 B. Chung.^1,2
Using Basiliximab Does Not Increase De Novo DSA Incidence but Reduces Cytomegalovirus Infections and Neoplastic Complications in Non-Sensitized Kidney Transplant Patients.

M. Marron-Wojewodzki,¹ I. Szwarc,¹ C. Rene,² J.-F. Eliaou,² G. Mourad,¹ M. Le Quintrec.^1,3
Using Buccal Swabs for Deceased Organ Donor HLA Typing.

C. Muse,² S. Longobardi,¹ I. Gimferrer,¹ J. Orlowski.²
Using Donors with False Positive HIV Tests – An Unexpected Benefit of the HOPE Act.

C. Durand,¹ S. Halpern,¹ G. Bismut,¹ B. Doby,¹ N. Desai,¹ A. Cameron,¹ S. Florman,² S. Lerner,² S. Huprikar,² J. Locke,³ S. Mehta,³ P. Stock,⁴ N. Neidlinger,⁵ D. Brown,¹ B. Haydel,² A. Redd,^1,6 A. Massie,¹ A. Tobian,¹ D. Segev.¹
Using Scheduled Commercial Flights for Transport of Liver for Transplant.

V. Gupta,¹ A. Chandra,¹ M. Singh,¹ V. Gupta,¹ S. Kumar,¹ P. Joshi,¹ P. Sharma,² H. Hasan,³ P. Srivastava,⁴ M. Khan,¹ Z. Arshad,¹ R. Kant.¹
Utility of “High-Dose” Ganciclovir in High Viral Load CMV Infection in Transplant Recipients.

M. Alfares, R. Avery, N. Turki, K. Alfares, S. Mehta, R. Boger, A. Valsamakis.
Utility of a 10-Minute Functional Test as a Predictor of Kidney Transplant (KTP) Listing.

M. Swee,^1,2 J. Hornickel,² R. Kalil.^1,2
Utility of Concomitant Biopsy in Simultaneous Pancreas Kidney Transplant Recipients in the Identification of Rejection of Pancreas and Kidney.

C. Johnson, K. Johnson, B. Kaplan, M. Temkit, R. Heilman, S. Sukumaran Nair, H. Khamash, J. Huskey, G. Mour, H. Chakkera.
Utility of Electron Microscopy in Kidney Transplant Biopsies.

J. Grodsky,¹ R. Craver,^1,2 I. Ashoor.²
Utility of IL-2 Complexes in Promoting Vascularized Composite Allograft Survival.

H. Xu,¹ S. Dahiya,² L. Wang,² T. Akimova,² W. Hancock,^2,4 S. Levin.³
Utility of Weighted Composite Endpoints in Kidney Transplantation.

J. Schold, D. Goldfarb, S. Flechner, L. Buccini, J. Augustine, E. Poggio.

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z